semaglutide and mucinex FBI issues safety warning about counterfeit versions of weight loss drug semaglutide and mucinex What's Next – Oral Semaglutide, the First Ingestible

These drugs are currently FDA-approved for type 2 diabetes and obesity not for alcohol use disorder

Reported Gastrointestinal Side Effects in Clinical Trials Phase 2 trial data show nausea, vomiting, diarrhoea, constipation, and upper abdominal pain are the most frequently reported gastrointestinal side effects, with incidence increasing at higher doses and most events being mild to moderate

It won't have the same degree of weight loss from what we can see in the early trials, she advises, but it will help retain lean muscle mass, which we inevitably lose over our lifetime. Given that semaglutide is a lifelong drug, the long-term data on GLP-1 agonists is reassuringly positive

Per CMS: "A provider does not need to be enrolled in Medicare in order to write a prescription or submit a prior authorization request for products provided under the Medicare GLP-1 Bridge to an eligible beneficiary." What this means in practice: you can use any qualified prescriber, including telehealth providers, cash-only practices, and clinicians who do not accept Medicare for office visits